← Stocks · CANF record
Signal record & history · Trifecta Signals
Can-Fite has been flagged by the Trifecta screener 1 time since 2025. 1 signal confirmed; the median confirmed signal is down 74.7% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Nov 2025 · Latest Nov 2025 · Confirmed 1 of 1 Early · Latest close in the chart data: Thu, Nov 5, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since November 2025, Can-Fite has had one Early signal, one confirmed. Its one decided signal gained +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for CANF and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Classified in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, Can-Fite BioPharma trades under the CANF ticker. Its market value of about $4.9 million places it in the small-cap group.
One run stands out on the record: a confirmation in November 2025 was followed by a fall of about 35% over the next 90 days. On classification, revenue was shrinking by about 16% at the time, and it sat in the large-cap group when that signal fired.
The stock closed Thursday, November 5 at $1.60, down 4.2% on the day. Recent trading has kept the shares between about $1.60 and $1.67 over the past week.
